Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Liabilities and Shareholders Equity (2016 - 2025)

MedWellAI (MWAI) has disclosed Liabilities and Shareholders Equity for 11 consecutive years, with $460888.0 as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 83.63% to $460888.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, down 77.03% year-over-year, with the annual reading at $805500.0 for FY2025, 79.57% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $460888.0 at MedWellAI, down from $549872.0 in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $16.3 million in Q2 2022, with the low at $460888.0 in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $8.3 million, with a median of $5.8 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity surged 2517.66% in 2021, then plummeted 84.0% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $16.2 million in 2021, then fell by 3.54% to $15.6 million in 2022, then plummeted by 65.07% to $5.4 million in 2023, then tumbled by 48.29% to $2.8 million in 2024, then tumbled by 83.63% to $460888.0 in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $460888.0, $549872.0, and $805500.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.